Bangladesh confirmed two more cases of the deadly Influenza A (H1N1) virus on Saturday, taking the total cases to 18, health officials said.

The two newly identified cases were infected through close contact with people already suffering from the flu, Head of the country's Institute of Epidemiology, Disease Control and Research (IEDCR) under the Health Ministry Mahmudur Rahman reportedly confirmed.

A Briton who lost one eye and blinded the other in an accident was able to see again after part of his tooth was implanted in his eye socket as part of a unique sight-restoration surgery.

Martin Jones, 42, of Rotherham, South Yorkshire saw his wife for the first time when doctors removed the bandage off his operated eye.

The influenza A (H1N1) pandemic has made fake Tamiflu the most spammed drug over the Internet surpassing spam e-mails on bogus male impotency drug Viagra, Britain's pharmaceutical body said Friday.

"From looking at sites that used to sell Viagra and the amount of spam emails we're having reported to us, we think that Tamiflu is now the most spammed drug on the Internet," David Pruce, Director of Policy for the UK's Royal Pharmaceutical Society (RPS) told CNN. "Every Web site that used to sell Viagra is now selling Tamiflu," Pruce added.

Researchers from the Sunnybrook Health Sciences Center in Toronto are studying the use of bacteria and viruses to find a solution how to prevent Alzheimer's disease. A team led by psychiatrist Dr. Paul Verhoeff reviewed previous studies done on the subject the past 10 years in a bid to find a link between different infections and Alzheimer's.

One bacteria they have stumbled upon is the Chlamydia pneumoniae, believed to be be the cause of 10 to 20 percent of pneumonia cases outside hospitals. The team discovered in one autopsy-based study that the Chlamydia bacteria was in 90 percent of the brains of 19 Alzheimer's sufferers, but was only in 5 percent of people with no Alzheimer's disease.

The results of talks between Health Canada and Pfizer Inc. will determine the course of action Ottawa will make if it will place safety warnings on packaging of anti-smoking drugs known to have psychiatric side effects such as suicidal thoughts.

Health Canada spokesperson Philippe Laroche said the agency expects an agreement with Pfizer may be signed by end of summer or fall.